Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Nusa Raya Cipta Tbk. (NRCA) Price & Performance

UBC Medical Indonesia Tbk.Trade
Nusa Raya Cipta Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Nusa Raya Cipta Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp167 (market cap 651.75B, 626.9K 24h volume), while Nusa Raya Cipta Tbk. trades at Rp525 (market cap 1.32T, 862.9K 24h volume). The key difference: Nusa Raya Cipta Tbk. is far larger — about 2× UBC Medical Indonesia Tbk.'s market cap, and Nusa Raya Cipta Tbk. is more actively traded (862.9K versus 626.9K). Which is the better fit depends on your goals.

LABSNRCA
Market Cap
651.75B1.32T
Volume
626.9K862.9K
Lot
6.27K8.63K
Turnover
103.6M450.84M
Average Price
165.25522.48
Value
103.6M450.84M
Indicative Equilibrium Price
165530
Indicative Equilibrium Volume
30010.7K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
NRCA
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Nusa Raya Cipta Tbk.

PT Nusa Raya Cipta Tbk (the Company) was establised based on notarial deed No. 134 of Ny Kartini Muljadi, SH., dated September 17, 1975.

Read more on NRCA